🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To compare the efficacy of insulin glargine (U300) and ...
Status
Completed
Location
Investigational Site Number 1560039
Start Date
2016-08-24
Trial ID
NCT02855684
Treatments Being Tested
The aim of this study is to explore the effectiveness of liraglutide combin...
Status
Completed
Location
The Third Affiliated Hospital of Sun Yat-sen University
Start Date
2014-08
Trial ID
NCT02147925
Primary Objective: 6 To assess the efficacy of insulin glargine given once...
Status
Completed
Location
Investigational Site Number 156006
Start Date
2011-02
Trial ID
NCT01223131
Treatments Being Tested
This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00851903
Treatments Being Tested
This is an open label, randomized, parallel group comparison of the immunog...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01352663
Treatments Being Tested
This is a multicenter, randomized, open, parallel group, active-controlled ...
Status
Completed
Location
Affiliated hospital of Weifang Medical University
Start Date
2015-06-19
Trial ID
NCT02491528
Treatments Being Tested
This is a randomised, double-blind, three-period crossover euglycaemic clam...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2022-05-12
Trial ID
NCT05373199
The primary objective is to demonstrate the non-inferiority at six months o...
Status
Completed
Location
Investigational Site Number 204
Start Date
2009-07
Trial ID
NCT00965549
Treatments Being Tested
The study is designed to approve non-inferior efficacy and safety of Insuli...
Status
Completed
Location
Arkhangelsk Regional Clinical Hospital
Start Date
2018-07-04
Trial ID
NCT04022993
Primary Objective: To demonstrate non-inferiority of SAR341402 versus Novo...
Status
Completed
Location
Investigational Site Number 8400040
Start Date
2017-08-02
Trial ID
NCT03211858
Treatments Being Tested